Teleflex Gets FDA 510(k) for New Central Catheter

Teleflex Incorporated Tuesday announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration for the company’s ArrowEVOLUTION PICC with Chlorag+ard technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally.
CNBC